List view / Grid view
Epilepsy is a complex neurological disorder that afflicts approximately 50 million people worldwide. Although this disease has been known to exist for centuries, the exact mechanism of its cardinal symptom, the epileptic seizure, remains poorly understood. In fact, roughly 25% of epileptic seizures can’t be controlled by any of the…
A collaborative study describes a novel myoclonic epilepsy syndrome in dogs for the first time and discovers its genetic cause at DIRAS1 gene.
26 August 2016 | By Niamh Louise Marriott, Digital Content Producer
At the onset of puberty, the emergence of a novel inhibitory brain receptor, α4βδ (alpha four beta delta), reduces epilepsy seizure-like activity in mouse...
22 July 2016 | By Niamh Louise Marriott, Digital Content Producer
Researchers have developed compounds that may prevent the development of epilepsy. In a new study, scientists found that these compounds prevented seizures and their damaging effects...
13 May 2016 | By Victoria White, Digital Content Producer
Scientists also found that inhibiting oestrogen synthesis just after seizure onset strongly suppressed seizures in both sexes...
27 October 2015 | By Victoria White
If the researchers blocked a central switch in epileptic mice, the frequency and severity of the seizures decreased...
20 July 2015 | By
Using existing drugs to restore basic biological processes in human cells, researchers may have devised effective treatments for mitochondrial diseases...
19 June 2015 | By SciFluor Life Sciences
SciFluor Life Sciences has announced that pre-clinical research demonstrating the potential effectiveness of its patented novel compound, SF0034, for treating epilepsy and preventing tinnitus was published in the peer-reviewed publication, The Journal of Neuroscience...
12 June 2015 | By Victoria White
A panel of experts will explore ground breaking research regarding the role of non-invasive stimulation of the vagus nerve in pain pathways at AHS 2015...
18 May 2015 | By Victoria White
Anavex revealed full preclinical anti-seizure data for its lead drug candidate, ANAVEX 2-73, at the Antiepileptic Drug Trials XIII Conference...
7 May 2015 | By Victoria White
University of British Columbia researchers have reported that a new anticonvulsant epilepsy drug holds promise as a treatment for Alzheimer’s disease...
8 January 2015 | By SciFluor Life Sciences
SciFluor Life Sciences, LLC, an emerging clinical stage biopharmaceutical company that creates innovative therapeutics for patients with ophthalmologic and neurologic disease, announced that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8,916,133 with claims covering the novel compound SF0034...
